Phase III, Long-term, Open-label Safety Study of Z-338

NCT01973790 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
207
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Zeria Pharmaceutical